Combined Therapies in a Murine Model of Blastoschizomycosis

Antimicrobial Agents and Chemotherapy
2007.0

Abstract

In a murine model of blastoschizomycosis, amphotericin B combined with micafungin, flucytosine or voriconazole did not improve the efficacy of fluconazole. However, such combinations can constitute therapeutic options for those cases where fluconazole fails.

Knowledge Graph

Similar Paper

Combined Therapies in a Murine Model of Blastoschizomycosis
Antimicrobial Agents and Chemotherapy 2007.0
Interactions between Triazoles and Amphotericin B in Treatment of Disseminated Murine Infection by Fusarium oxysporum
Antimicrobial Agents and Chemotherapy 2009.0
Posaconazole Enhances the Activity of Amphotericin B against Hyphae of Zygomycetes In Vitro
Antimicrobial Agents and Chemotherapy 2008.0
Liposomal Amphotericin B and Echinocandins as Monotherapy or Sequential or Concomitant Therapy in Murine Disseminated and Pulmonary Aspergillus fumigatus Infections
Antimicrobial Agents and Chemotherapy 2010.0
Combination of Amphotericin B with Flucytosine Is Active In Vitro against Flucytosine-Resistant Isolates of Cryptococcus neoformans
Antimicrobial Agents and Chemotherapy 2007.0
Optimization of the Dosage of Flucytosine in Combination with Amphotericin B for Disseminated Candidiasis: a Pharmacodynamic Rationale for Reduced Dosing
Antimicrobial Agents and Chemotherapy 2007.0
Efficacy of Triazoles in a Murine Disseminated Infection by Candida krusei
Antimicrobial Agents and Chemotherapy 2009.0
Murine Model of a Disseminated Infection by the Novel Fungus Fonsecaea monophora and Successful Treatment with Posaconazole
Antimicrobial Agents and Chemotherapy 2010.0
In Vitro Susceptibilities of 217 Clinical Isolates of Zygomycetes to Conventional and New Antifungal Agents
Antimicrobial Agents and Chemotherapy 2007.0
Posaconazole Enhances the Activity of Amphotericin B against Aspergillus Hyphae In Vitro
Antimicrobial Agents and Chemotherapy 2007.0